The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea

Hepato-Gastroenterology

Volumn 58, Issue 105, 2011, Pages 246-250

  Chung, Jun Won ^a   Lee, Gin Hyug ^b   Han, Jeung Hye ^b   Jeong, Jin Yong ^b   Choi, Kwi Sook ^b   Kim, Do Hoon ^b   Jung, Kee Wook ^b   Choi, Kee Don ^b   Song, Ho June ^b   Jung, Hwoon Yong ^b   Kim, Jin Ho ^b  

^a Gachon University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Bismuth; Clarithromycin; Helicobacter pylori; Triple therapy

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; ESOMEPRAZOLE; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; TETRACYCLINE;

ARTICLE; DEMOGRAPHY; DRUG EFFICACY; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STOMACH ULCER; UREA BREATH TEST;

AMOXICILLIN; BISMUTH; BREATH TESTS; CLARITHROMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; METRONIDAZOLE; PHYSICIAN'S PRACTICE PATTERNS; PROTON PUMP INHIBITORS; REPUBLIC OF KOREA; TETRACYCLINE; TREATMENT OUTCOME;

EID: 79955006788     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Chey WD, Wong BC: American college of gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol 2007;102:1808-25. (Pubitemid 47206706)
2. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ: Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007;56:772-81. (Pubitemid 46854190)
3. Korean Helicobacter pylori Study Group: Diagnosis and treatment of Helicobacter pylori infection in Korea. Korean J Gastroenterol 1998;32:275-89.
4. Gisbert JP, Gonzalez L, Calvet X, Garcia N, Lopez T, Rogue M, Gabriel R, Pajares JM: Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000;14:1319-28.
5. Nista EC, Candelli M, Cremonini F, Cazzato IA, Di Caro S, Gabrielli M, Santarelli L ,Zocco MA, Ojetti V, Carloni E, Cammarota G, Gasbarrini G, Gasbarrini A: Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial. Aliment Pharmacol Ther 2003;18:627-33.
6. Cheon JH, Kim N, Lee DH, Kim JM, kim JS, Jung HC, Song IS: Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection. Helicobacter 2006;11:46-51.
7. Perri F, Festa V, Merla A, Barberani F, Pilotto A, Andriulli A: Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy. Aliment Pharmacol Ther 2003;18:815-20.
8. Fischbach L and Evans EL: Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther 2007;26:343-57. (Pubitemid 47063149)
9. Kim JJ, Reddy R, Lee M, Kim JG, Fouad AK, El-Zaatari K, Osato MS, Graham DY, Kwon DH: Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother 2001;47:459-61. (Pubitemid 32303414)
10. Kobayashi I, Murakami K, Kato M, Kato S, Azuma T, Takahashi S, Uemura N, Katsuyama T, FuKuda Y, Hamura K, Nasu M, Fujioka T: Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005. J Clin Microbiol 2007;45:4006-10.
11. Choi YS, Cheon JH, Lee JY, Kim SG, Kim JS, Kim N, Lee DH, Kim JM, Jung HC, Song IS: The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years. Korean J Gastroenterol 2006;48:156-61.
12. Na HS, Hong SJ, Yoon HJ, Maeng JH, Ko BM, Jung IS, Ryu CB, Kim JO, Cho JY, Lee JS, Lee MS, Shim CS, Kim BS: Eradication rate of first-line and second-line therapy for Helicobacter pylori infection, and reinfection rate after successful eradication. Korean J Gastroenterol 2007;50:170-5.
13. Choung RS, Lee SW, Jung SW, Han WS, Kim MJ, Jeen YT, Park JJ, Lee HS, Chun HJ, Um SH, Choi JH, Kim CD, Ryu HS, Hyun JH: Comparison of the effectiveness of quadruple salvage regimen for Helicobacter pylori infection according to the duration of treatmen. Korean J Gastroenterol 2006;47:131-5.
14. Chung WC, Cho YS, Jeong JJ, Lee IS, Kim SW, Yang JM, Choi MG, Chung IS, Park DH: Eradication rate of Helicobacter pylori according to the diseases and therapeutic regimen, and reinfection rate after successful eradication in a tertiary clinic. Korean J Gastroenterol 2003;41:1-8.
15. Lee JH, Cheon JH, Park MJ, Kim N, Lee DH, Kim JM, Kim JS, Jung HC, Song IS: The trend of eradication rates of second-line quadruple therapy containing metronidazole for Helicobacter pylori infection: an analysis of recent eight years. Korean J Gastroenterol 2005;46:94-8.
16. 13C-Urea breath test, using a new compact nondispersive isotope-selective infrared spectrophotometer: comparison with mass spectrometry. J Gastroenterol 2004;39:629-34. (Pubitemid 39149349)
17. Lam SK and Talley NJ: Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998;13:1-12.
18. Vakil N, Lanza F, Schwartz H, Barth J: Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther 2004;20:99-107. (Pubitemid 38938723)
19. Paoluzi P, Iacopini F, Crispino P, Nardi F, Bella A, Rivera M, Rossi P, Gurnari M, Caracciolo F, Zippi M, Pica R: 2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study. Helicobacter 2006;11:562-8. (Pubitemid 44674141)
20. Kim BG, Lee DH, Ye BD, Lee KH, Kim BW, Kim SG, Kim SW, Kim SK, KimJJ, Kim HY, Park JJ, Park CY, Baik GH, Lee YC, Lee JH, Lee JH, Chun HJ, Hahm KB, Hong SJ, Lee SW, Jung HC: Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy for Helicobacter pylori eradication: neither treatment duration provides acceptable eradication rate in Korea. Helicobacter 2007;12:31-5. (Pubitemid 46105916)
21. Cho HJ, Bae RC, Lee SH, Jang SI, Lee HS, Choi SY, Shin KY, Heo J, Kim SK, Jung MK, Jeon SW. The trend in the eradication rates of first- and second-line therapy for Helicobacter pylori infection in Daegu and Kyungpook provinces: a single center experience for the most recent 9 years. Korean J Med 2009;76:186-192.
22. Kim N, Kim JM, Kim CH, Park YS, Lee DH, Kim JS, Jung HC, Song IS: Institutional difference of antibiotic resistance of Helicobacter pylori strains in Korea. J Clin Gastroenterol 2006;40:683-7. (Pubitemid 44350587)
23. Sung HS, Chung HJ, Kim M-N, Lee GH: Clinical Usefulness of Antimicrobial Susceptibility Test for Helicobacter pylori. Korean J Lab Med 2006;26:179-84.
24. Bang SY, Han DS, Eun CS, Kim JE, Ahn SB, Sohn JH, Jeon YC, Kang JO: Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease. Korean J Gastroenterol 2007;50:356-62.
25. Kim JM, Kim JS, Jung HC,Kim N, Kim YJ, Song IS: Antibiotic resistance of Helicobacter pylori isolated from Korean patients in 2003. Korean J Gastroenterol 2004;44:126-35.
26. Lee HK, Chae HS, Kang JO, Lee MK, Sung HS, Kim MN, Lee JW, Lee M, Shim KN: Multicenter study for the frequency of 23s rRNA point mutations associated with clarithromycin resistance in Helicobacter pylori in Korea. Korean J Clin Microbiol 2008;11:84-89.
27. Furuta T, Shirai N, Kodaira M, Sugimoto M, Nogaki A, Iwaizumi M, Yamade M, Terekawa I, Ohashi K, Ishizaki T, Hidhisa A: Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of Helicobacter pylori. Clin Pharmacol Ther 2007;81:521-8. (Pubitemid 46452299)
28. Zullo A, De Francesco V, Hassan C, Morini S, Vaira D: The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007;56:1353-7. (Pubitemid 47517826)
29. Choi WH, Park DI, Oh SJ, Baek YH, Song CH, Hong EJ, Song MJ, Park SK, Park JH, Cho YK, Sohn CI, Jeon WK, Kim BI: Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea. Korean J Gastroenterol 2008;51:280-4.
30. Jafri NS, Hornoung CA, Howden CW: Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann intern Med. 2008;148:923-31 (Pubitemid 351860824)
31. Gisbert JP: "Rescue" regimens after Helicobacter pylori treatment failure. World J Gastroenterol 2008;14:5385-402.
32. Eun CS, Han DS, Park JY, Jeon YC, Hahm JS, Kim KS, Kang JO: Changing pattern of antimicrobial resistance of Helicobacter pylori in Korean patients with peptic ulcer diseases. J Gastroenterol 2003;38:436-41. (Pubitemid 36701577)
33. Kim JM: Antibiotic resistance of Helicobacter pylori isolated from Korean patients. Korean J Gastroenterol 2006;47:337-49.
34. Jang S-M: Comparative analysis of drug misuse after the separation of prescribing and dispensing practice Korean Institute for Health and Social Welfare Reports 2001; 97-103
35. Houben MH, van de Beek D, Hensen EF, Craen AJ, Rauws EA, Tytgat GN: A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther 1999;13:1047-55. (Pubitemid 29374105)
36. Katelaris PH, Forbes GM, Talley NJ, Crotty B: A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE Study. Gastroenterology 2002;123:1763-9. (Pubitemid 35408299)